Skip to main content

Table 2 Comparison of adverse events associated with sleep medication use and delirium

From: Efficacy of a melatonin receptor agonist and orexin receptor antagonists in preventing delirium symptoms in the olderly patients with stroke: a retrospective study

Adverse events, n (%)

Consecutive administration group

n = 33

Non-consecutive administration group

n = 71

p value

Somnolence

6 (18.2)

11 (15.5)

0.78

Drowsiness

1 (3.0)

2 (2.8)

> 0.99

Lightheadedness

8 (24.2)

15 (21.1)

0.80

Dizziness

0 (0)

4 (5.6)

0.30

Hepatic impairment

0 (0)

1 (1.4)

> 0.99

Renal impairment

2 (6.1)

2 (2.8)

0.58

Self-extraction of intravascular tube

5 (15.2)

5 (7.0)

0.28